GHE treatment significantly reduced proinflammatory IL-6 and TNF-α levels compared to RA and RA + MTX groups, highlighting its enhanced anti-inflammatory activity due to phenolic compounds identified through HPLC analysis [43]. The gene discussed is IL6; the disease is rheumatoid arthritis.